China SXT Pharmaceuticals (China SXT Pharmaceuticals) Price-to-Owner-Earnings : (As of Jun. 06, 2024)

View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals Price-to-Owner-Earnings?

As of today (2024-06-06), China SXT Pharmaceuticals's share price is $1.13. China SXT Pharmaceuticals does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.

The historical rank and industry rank for China SXT Pharmaceuticals's Price-to-Owner-Earnings or its related term are showing as below:

SXTC's Price-to-Owner-Earnings is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 25.47
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-06), China SXT Pharmaceuticals's share price is $1.13. China SXT Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-29.05. Therefore, China SXT Pharmaceuticals's PE Ratio for today is At Loss.

As of today (2024-06-06), China SXT Pharmaceuticals's share price is $1.13. China SXT Pharmaceuticals's EPS without NRI for the trailing twelve months (TTM) ended in was $-29.05. Therefore, China SXT Pharmaceuticals's PE Ratio without NRI for today is At Loss.

During the past 7 years, China SXT Pharmaceuticals's highest PE Ratio without NRI was 141.10. The lowest was 0.00. And the median was 32.78.

China SXT Pharmaceuticals Price-to-Owner-Earnings Historical Data

The historical data trend for China SXT Pharmaceuticals's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Price-to-Owner-Earnings Chart

China SXT Pharmaceuticals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Owner-Earnings

Get a 7-Day Free Trial

China SXT Pharmaceuticals Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Price-to-Owner-Earnings	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of China SXT Pharmaceuticals's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, China SXT Pharmaceuticals's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China SXT Pharmaceuticals's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China SXT Pharmaceuticals's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where China SXT Pharmaceuticals's Price-to-Owner-Earnings falls into.

China SXT Pharmaceuticals Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

China SXT Pharmaceuticals's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	1.13	/	-16.92
	=

China SXT Pharmaceuticals (NAS:SXTC) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

China SXT Pharmaceuticals Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

China SXT Pharmaceuticals (China SXT Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Price-to-Owner-Earnings

Comparable Companies

Traded in Other Exchanges

2RY0:Germany

Address

No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300

Website

http://www.sxtchina.com

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.